Stock ACHFF ARCH BIOPARTNERS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Arch Biopartners Inc.

Equities

ACHFF

CA03938C1041

Market Closed - OTC Markets
Other stock markets
 15:53:26 2024-06-21 EDT 		5-day change 1st Jan Change
1.21 USD -3.20% Intraday chart for Arch Biopartners Inc. -1.63% +8.37%
06-18 Arch Biopartners Obtains University of Calgary Ethics Approval to Proceed with Phase II Trial MT
06-18 Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury (CS-AKI) CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Arch Biopartners Initiated at Market Perform, $3.50 Target Price at Raymond James
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ACHFF Stock
  4. News Arch Biopartners Inc.
  5. Analyst Reco.